SENSIENT TECHNOLOGIES CORP·4

Apr 1, 12:29 PM ET

Carleone Joseph 4

4 · SENSIENT TECHNOLOGIES CORP · Filed Apr 1, 2026

Research Summary

AI-generated summary of this filing

Updated

SENSIENT (SXT) Director Joseph Carleone Receives 422.547-Share Award

What Happened

  • Joseph Carleone, a director of SENSIENT TECHNOLOGIES CORP (SXT), received an award of 422.547 shares (derivative) on 2026-03-31. The grant price is recorded as $0.00, so no cash was paid; the transaction is reported as an Award/Grant (code A).
  • This award represents restricted/deferred stock issued under the issuer's director compensation arrangements (see footnotes). It is not an open-market purchase or sale and should be viewed as compensation rather than a market investment signal.

Key Details

  • Transaction date: 2026-03-31; filing date: 2026-04-01 (timely).
  • Security: 422.547 derivative shares granted at $0.00 (total value reported $0).
  • Transaction code: A (award/grant).
  • Post-transaction holdings: Not specified in the supplied filing summary.
  • Relevant footnotes from the filing:
    • F1: Includes restricted stock under the 2017 Stock Plan and shares in a dividend reinvestment plan.
    • F2: Deferred stock converts to common stock on a one-for-one basis.
    • F3: Grant reflects deferral of director fees under the Directors' Deferred Compensation Plan.
    • F4: Shares of common stock will be issued upon termination of the reporting person's service as a director.
  • Implication for investors: This is a routine director compensation grant (deferred/restricted stock), not a market purchase or sale. It increases potential future common shares once vested/issued per plan terms.

Insider Transaction Report

Form 4
Period: 2026-03-31
Transactions
  • Award

    Deferred Stock

    [F2][F3][F4]
    2026-03-31+422.54723,780.4 total
    Common Stock (422.547 underlying)
Holdings
  • Common Stock

    [F1]
    22,551.313
Footnotes (4)
  • [F1]Includes shares of restricted stock held under Issuer's 2017 Stock Plan, as amended and restated, and shares held in a dividend reinvestment plan.
  • [F2]Deferred stock converts to common stock on a one-for-one basis.
  • [F3]Deferral of director fees under Issuer's Directors' Deferred Compensation Plan.
  • [F4]Shares of common stock will be issued upon termination of reporting person's service as a director of the Issuer.
Signature
/s/ John J. Manning, Attorney-in-Fact for Dr. Carleone|2026-04-01

Documents

1 file
  • 4
    form4.xmlPrimary

    PRIMARY DOCUMENT